Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-SPIRIT: Filgrastim vs placebo in acute cervical spinal cord injury
jRCT2091220217Phase 3Completed
- Sponsor
- Coordinating Committee
- Start
- Jul 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute spinal cord injury (SCI) comparing Filgrastim with Placebo (2 arms). Primary endpoint: Transition of motor paralysis. Started Jul 2015; status: completed.
02
Drugs
filgrastim
03
Conditions
acute spinal cord injury (SCI)
Beyond the preview
Go deeper on jRCT2091220217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220217.